Related Experiment Videos

Mineralocorticoid excess, dietary sodium, and myocardial fibrosis

C G Brilla1, K T Weber

  • 1Division of Cardiology, University of Missouri-Columbia 65212.

Insights

Mineralocorticoid excess, such as aldosterone (ALDO) and deoxycorticosterone acetate (DOCA), causes hypertension and cardiac fibrosis in rats. However, glycyrrhizic acid (GA), a mineralocorticoid-like substance, did not induce myocardial fibrosis.

Area of Science:

  • Cardiovascular Physiology
  • Endocrinology
  • Pathology

Background:

  • Arterial hypertension linked to hyperaldosteronism involves collagen accumulation in coronary arteries and ventricles.
  • This fibrosis is hypothesized to be driven by mineralocorticoid excess rather than ventricular pressure overload.

Purpose of the Study:

  • To investigate the role of mineralocorticoid excess in causing cardiac fibrosis.
  • To compare the effects of aldosterone (ALDO), deoxycorticosterone acetate (DOCA), and glycyrrhizic acid (GA) on cardiac tissue in the presence of high sodium intake.

Main Methods:

  • Uninephrectomized rats on a high-sodium diet were infused with D-aldosterone (ALDO), administered deoxycorticosterone acetate (DOCA), or given glycyrrhizic acid (GA).
  • Control groups included untreated rats, rats with high sodium only, and rats receiving ALDO with sodium deprivation.
  • Fibrous tissue response was assessed after 8 weeks.

Main Results:

  • All mineralocorticoid excess groups (ALDO, DOCA) developed hypertension and left ventricular hypertrophy.
  • ALDO infusion increased collagen volume fraction, while DOCA increased perivascular collagen.
  • Glycyrrhizic acid (GA) and control groups did not exhibit myocardial fibrosis.

Conclusions:

  • Chronic administration of ALDO or DOCA, in the context of high sodium intake, leads to collagen accumulation and myocardial fibrosis in rats.
  • Mineralocorticoid-like compound GA does not induce myocardial fibrosis under similar conditions.
  • These findings underscore the specific role of mineralocorticoid excess in mediating cardiac fibrosis.

Related Concept Videos